| Panel naam | NGS Dyslipidemie |
|---|---|
| Panel methode | Targeted NGS |
| Panel versie ** | DLv5 |
| Panel kwaliteit *** | A |
| Core-NL | Geen core-NL genen inbegrepen |
| CNV analyse | Ja |
| Locatie | Locatie AMC |
| Genen (30) | Kwaliteit | % coverage >30 | % coverage >20 | Core-NL | Notitie |
|---|---|---|---|---|---|
| ABCA1 | A | 100.0 | 100.0 | ||
| ABCG5 | A | 100.0 | 100.0 | ||
| ABCG8 | A | 100.0 | 100.0 | ||
| ANGPTL3 | A | 100.0 | 100.0 | ||
| APOA1 | A | 100.0 | 100.0 | ||
| APOA5 | A | 100.0 | 100.0 | ||
| APOB | A | 100.0 | 100.0 | ||
| APOC2 | A | 100.0 | 100.0 | ||
| APOC3 | A | 100.0 | 100.0 | ||
| APOE | A | 100.0 | 100.0 | ||
| CETP | A | 100.0 | 100.0 | ||
| CYP27A1 | A | 100.0 | 100.0 | ||
| CYP7A1 | A | 100.0 | 100.0 | ||
| GPD1 | A | 100.0 | 100.0 | ||
| GPIHBP1 | A | 100.0 | 100.0 | ||
| LCAT | A | 100.0 | 100.0 | ||
| LDLR | A | 100.0 | 100.0 | ||
| LDLRAP1 | A | 100.0 | 100.0 | ||
| LIPA | A | 100.0 | 100.0 | ||
| LIPC | A | 100.0 | 100.0 | ||
| LIPG | A | 100.0 | 100.0 | ||
| LMF1 | A | 100.0 | 100.0 | ||
| LPA | A | 100.0 | 100.0 | ||
| LPL | A | 100.0 | 100.0 | ||
| MTTP | A | 100.0 | 100.0 | ||
| MYLIP | A | 100.0 | 100.0 | ||
| PCSK9 | A | 100.0 | 100.0 | ||
| SAR1B | A | 100.0 | 100.0 | ||
| SCARB1 | A | 100.0 | 100.0 | ||
| SLCO1B1 | A | 100.0 | 100.0 |
| Indicatie(s) |
|---|
** Voor informatie over eerdere versies van dit panel neem contact op met het laboratorium Genoomdiagnostiek
*** NGS panel genen kunnen met verschillende kwaliteit worden geanalyseerd. Meer informatie over testkwaliteit type A, C or A/C